Optimizing target inactivation to treat multidrug-resistant <i>Escherichia coli</i> with NDM and PBP3 mutations: "going the extra mile". [PDF]
Fabrizio C +13 more
europepmc +1 more source
Sulbactam-Durlobactam in the Treatment of Multidrug-Resistant <i>Acinetobacter baumannii:</i> A Narrative Review. [PDF]
Viscardi S +3 more
europepmc +1 more source
In vitro activity of aztreonam/avibactam and comparators against Enterobacterales isolates from patients with hospital-acquired pneumonia, ventilator-associated pneumonia, and complicated intra-abdominal infections (ATLAS, 2021-2022). [PDF]
Yang Q +7 more
europepmc +1 more source
Phytochemical profiling and multi-target antibacterial in silico potential of Algerian wild sea buckthorn leaves. [PDF]
Chenni FZ +6 more
europepmc +1 more source
Molecular Insights into the β‑Lactam α‑Methyl Modulation of <i>Pseudomonas aeruginosa</i> Penicillin-Binding Protein 3 (PBP3): Loop Dynamics and Hydration Network Modulation. [PDF]
Reyes DV, Nellas RB.
europepmc +1 more source
Sulbactam-Durlobactam for Carbapenem-Resistant <i>Acinetobacter baumannii-calcoaceticus</i> Complex. [PDF]
Nappi F.
europepmc +1 more source
Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant <i>Escherichia coli</i>. [PDF]
Shropshire WC +16 more
europepmc +1 more source
Recurrent Campylobacter jejuni bacteraemia with independent acquisition of carbapenem resistance in three ST9611 isolates: a case series in immunocompromised hosts. [PDF]
Ngiam JN +5 more
europepmc +1 more source
Characteristics of Haemophilus influenzae Isolates Responsible for Invasive Infections in Poland in 2018-2023. [PDF]
Kiedrowska M +7 more
europepmc +1 more source
Structure-Activity Relationship and Crystallographic Study of New Monobactams. [PDF]
Kavaš V +10 more
europepmc +1 more source

